Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2013
12/25/2013EP2675787A1 Aminoindane compounds and use thereof in treating pain
12/25/2013EP2163553B1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/25/2013CN103476770A Novel salts and polymorphic forms of afatinib
12/25/2013CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103476766A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
12/25/2013CN103476759A Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
12/25/2013CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
12/25/2013CN103467459A Processes for preparing compound
12/25/2013CN103467458A Preparation methods for rosuvastatin calcium and intermediates thereof
12/25/2013CN103467456A 3,5-disubstituted indolone derivatives and their preparation method and use
12/25/2013CN103467450A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467423A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
12/25/2013CN103467417A Arctigenin carboxamide derivative, preparation method thereof, composition comprising arctigenin carboxamide derivative and uses thereof
12/25/2013CN103467388A Method for synthesizing aryl or heteroaryl substituted quinazoline compound
12/25/2013CN103467227A Method for preparing chiral piperidone
12/25/2013CN102311427B Rosinyl epoxy resin with bismaleimide structure and preparation method thereof
12/25/2013CN102272120B Biologically active amides
12/25/2013CN102146076B Anilinoquinazoline derivatives and preparation method thereof
12/25/2013CN101723768B Method for carrying out hydroxyethylation on phenolic acid compounds and products thereof
12/25/2013CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application
12/24/2013US8614335 Process and intermediates useful in the preparation of statins, particularly atorvastatin
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/24/2013US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications
12/24/2013US8614231 Immunosuppressor based on the blockage of TCR-Nck interaction
12/24/2013US8614211 Certain chemical entities, compositions, and methods
12/24/2013US8614010 Aromatic amine derivative, and organic electroluminescent element
12/24/2013CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
12/24/2013CA2600606C Indanes
12/24/2013CA2565200C Raf modulators and methods of use
12/24/2013CA2561059C Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
12/24/2013CA2500822C Nodulisporic acid derivative spot-on formulations for combating parasites
12/19/2013WO2013187689A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
12/19/2013WO2013186692A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
12/19/2013WO2013186159A1 New diazaspirocycloalkane and azaspirocycloalkane
12/19/2013WO2013185209A1 Forms of vilazodone and processes for the preparation thereof
12/19/2013US20130338374 Gpr 17 agonists and screening assay
12/19/2013US20130338368 Method for analysis of protein and analytical reagent
12/19/2013US20130338187 Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
12/19/2013US20130338171 Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
12/19/2013US20130338170 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/19/2013US20130338167 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety
12/19/2013US20130338159 Bi-heteroaryl compounds as vps34 inhibitors
12/19/2013US20130338158 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
12/19/2013US20130338155 Method for treating infections
12/19/2013US20130338154 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/19/2013US20130338147 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/19/2013US20130338112 Compounds for the treatment of proliferative disorders
12/19/2013US20130336965 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
12/19/2013US20130336920 Compounds and methods for inhibiting phosphate transport
12/19/2013CA2876741A1 Forms of vilazodone and processes for the preparation thereof
12/18/2013EP2674429A1 Biscarbazole derivative and organic electroluminescent element using same
12/18/2013EP2674428A1 Modulators of ATP-binding cassette transporters
12/18/2013EP2673271A1 Hepatitis c virus inhibitors
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013EP2673267A1 1,3-dioxan-5-one compounds
12/18/2013EP2673264A1 Microbiocidal pyrazole derivatives
12/18/2013EP2673263A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
12/18/2013EP2672823A1 S1p modulating agents
12/18/2013EP2672821A1 Cathepsin c inhibitors
12/18/2013EP2421832B1 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
12/18/2013EP2398793B1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/18/2013CN103459382A Heterocyclic compounds for the inhibition of pask
12/18/2013CN103459375A Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
12/18/2013CN103450132A Synthesis and preparation method of novel sulfanilamide-coumarin derivatives
12/18/2013CN103446981A Novel TGIC (triglycidyl isocyanurate) continuous cyclization feed kettle
12/18/2013CN103446980A Novel TGIC (triglycidyl isocyanurate) continuous cyclization device
12/18/2013CN102102015B Coumarin derivative type organic electroluminescent material and preparation method and applications thereof
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101621998B Benzimidazole cannabinoid agonists bearing substituted heterocyclic group
12/18/2013CN101410387B Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/17/2013US8609860 Acid-labile trigger units
12/17/2013US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
12/17/2013US8609700 Pyridine compounds for controlling invertebrate pests I
12/17/2013US8609692 TRPV1 antagonists
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013CA2749114C Heteroatom-containing cyclic compound
12/17/2013CA2733533C Hedgehog pathway modulators
12/17/2013CA2611893C Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5
12/17/2013CA2527583C Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/12/2013WO2013184934A1 Neprilysin inhibitors
12/12/2013WO2013183800A1 Crystalline t-butyl 2-[(4r,6s)-6-formyl-2, 2-dimethyl-1,3-dioxane-4-yl]acetate and preparation method therefor
12/12/2013WO2013182946A2 Process for the preparation of vilazodone hydrochloride
12/12/2013WO2013182850A1 Isobenzofuran- 5 -yl-oxy- (hetero) aryl - imidazolidine - 2, 4 -dione derivatives modulators of kv3 potassium channels for the treatment of cns disorders.
12/12/2013WO2013182433A1 A process using grignard reagents
12/12/2013US20130331578 Novel iminosugars and their applications
12/12/2013US20130331568 Acetylene derivatives having mglur 5 antagonistic activity
12/12/2013US20130331567 Modulators of atp-binding cassette transporters
12/12/2013US20130331414 Inhibitors of Retroviral Replication
12/12/2013US20130331408 Opioid Receptor Ligands and Methods of Using and Making Same
12/12/2013US20130331396 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
12/12/2013US20130330366 Neprilysin inhibitors
12/12/2013US20130330365 Neprilysin inhibitors
12/12/2013US20130330284 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof
12/12/2013CA2876024A1 Neprilysin inhibitors
12/11/2013EP2670744A1 Pyrrole derivatives used as modulators of alpha7 nachr
12/11/2013EP2670737A1 Method of preparation of metaxalone
12/11/2013EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
12/11/2013CN103443096A Pyrimidine gyrase and topoisomerase iv inhibitors
12/11/2013CN103443094A Pyrazole derivative
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 694